Transcriptional	O
regulation	O
of	O
the	O
pyruvate	B-DNA
kinase	I-DNA
erythroid-specific	I-DNA
promoter	I-DNA
.	O

Mammal	B-protein
pyruvate	I-protein
kinases	I-protein
are	O
encoded	O
by	O
two	O
genes	O
.	O

The	O
L	B-DNA
gene	I-DNA
produces	O
the	O
erythroid	B-protein
(	O
R-PK	B-protein
)	O
or	O
the	O
hepatic	B-protein
(	I-protein
L-PK	I-protein
)	I-protein
isozymes	I-protein
by	O
the	O
alternative	O
use	O
of	O
two	O
promoters	B-DNA
.	O

We	O
report	O
the	O
characterization	O
of	O
the	O
cis-	B-DNA
and	I-DNA
trans-acting	I-DNA
elements	I-DNA
involved	O
in	O
the	O
tissue-specific	O
activity	O
of	O
the	O
L	B-DNA
gene	I-DNA
erythroid	I-DNA
promoter	I-DNA
.	O

A	O
R-PK	B-DNA
DNA	I-DNA
fragment	I-DNA
extending	O
from	O
-870	O
to	O
+54	O
relative	O
to	O
the	O
cap	B-DNA
site	I-DNA
confers	O
erythroid	O
specificity	O
to	O
a	O
reporter	B-DNA
gene	I-DNA
.	O

Within	O
this	O
region	O
,	O
we	O
define	O
a	O
minimal	B-DNA
promoter	I-DNA
(	O
-62	O
to	O
+54	O
)	O
that	O
displays	O
erythroid-specific	O
activity	O
and	O
contains	O
two	O
DNA	O
binding	O
sites	O
.	O

One	O
,	O
located	O
at	O
-50	O
,	O
binds	O
members	O
of	O
the	O
CCACC/Sp1	B-protein
family	I-protein
and	O
the	O
other	O
,	O
located	O
at	O
-20	O
,	O
binds	O
the	O
erythroid	B-protein
factor	I-protein
GATA-1	I-protein
.	O

Although	O
the	O
-20	O
GATA	B-DNA
binding	I-DNA
site	I-DNA
(	O
AGATAA	O
)	O
is	O
also	O
a	O
potential	O
TFIID	B-DNA
binding	I-DNA
site	I-DNA
,	O
it	O
does	O
not	O
bind	O
TFIID	B-protein
.	O

Furthermore	O
,	O
the	O
substitution	O
of	O
this	O
GATA	B-DNA
binding	I-DNA
site	I-DNA
by	O
a	O
canonical	O
TFIID	B-DNA
binding	I-DNA
site	I-DNA
suppresses	O
the	O
promoter	O
activity	O
.	O

Mutations	O
and	O
deletions	O
of	O
both	O
sites	O
indicate	O
that	O
only	O
the	O
association	O
of	O
CCACC/Sp1	B-protein
and	O
GATA	B-DNA
binding	I-DNA
sites	I-DNA
can	O
drive	O
efficient	O
and	O
tissue-specific	O
expression	O
of	O
this	O
R-PK	B-protein
minimal	B-DNA
promoter	I-DNA
.	O

Finally	O
,	O
by	O
co-transfection	O
experiments	O
,	O
we	O
study	O
the	O
elements	O
involved	O
in	O
the	O
hGATA-1	O
transactivation	O
of	O
the	O
R-PK	B-DNA
promoter	I-DNA
in	O
HeLa	B-cell_line
cells	I-cell_line
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

268	NULL
,	NULL
No	NULL
.	NULL

8	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

5431-5437	NULL
,	NULL
1993	NULL
Printed	NULL
in	NULL
U.8.A	NULL
.	NULL

Transcriptional	NULL
Regulation	NULL
of	NULL
the	NULL
Pyruvate	NULL
Kinase	NULL
Erythroid-specific	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
July	NULL
17	NULL
,	NULL
1992	NULL
)	NULL
Isabelle	NULL
Max-Audit	NULL
,	NULL
Jean-Francois	NULL
Eleouet	NULL
}	NULL
,	NULL
and	NULL
Paul-Henri	NULL
Roméo	NULL
From	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
U.91	NULL
,	NULL
Hopital	NULL
Henri	NULL
Mondor	NULL
,	NULL
94010	NULL
Créteil	NULL
,	NULL
France	NULL
Mammal	NULL
pyruvate	NULL
kinases	NULL
are	NULL
encoded	NULL
by	NULL
two	NULL
genes	NULL
.	NULL

The	NULL
L	NULL
gene	NULL
produces	NULL
the	NULL
erythroid	NULL
(	NULL
R-PK	NULL
)	NULL
or	NULL
the	NULL
hepatic	NULL
(	NULL
L-PK	NULL
)	NULL
isozymes	NULL
by	NULL
the	NULL
alternative	NULL
use	NULL
of	NULL
two	NULL
promoters	NULL
.	NULL

We	NULL
report	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
cis-and	NULL
trans-acting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
tissue-specific	NULL
activity	NULL
of	NULL
the	NULL
L	NULL
gene	NULL
erythroid	NULL
promoter	NULL
.	NULL

A	NULL
R-PK	NULL
DNA	NULL
fragment	NULL
extending	NULL
from	NULL
-870	NULL
to	NULL
+54	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
confers	NULL
erythroid	NULL
specificity	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

Within	NULL
this	NULL
region	NULL
,	NULL
we	NULL
define	NULL
a	NULL
minimal	NULL
promoter	NULL
(	NULL
-62	NULL
to	NULL
+54	NULL
)	NULL
that	NULL
displays	NULL
erythroid-specific	NULL
activity	NULL
and	NULL
contains	NULL
two	NULL
DNA	NULL
binding	NULL
sites	NULL
.	NULL

One	NULL
,	NULL
located	NULL
at	NULL
-50	NULL
,	NULL
binds	NULL
members	NULL
of	NULL
the	NULL
CCACC/Sp1	NULL
family	NULL
and	NULL
the	NULL
other	NULL
,	NULL
located	NULL
at	NULL
-20	NULL
,	NULL
binds	NULL
the	NULL
erythroid	NULL
factor	NULL
GATA-1	NULL
.	NULL

Although	NULL
the	NULL
-20	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
AGATAA	NULL
)	NULL
is	NULL
also	NULL
a	NULL
potential	NULL
TFIID	NULL
binding	NULL
site	NULL
,	NULL
it	NULL
does	NULL
not	NULL
bind	NULL
TFIID	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
substitution	NULL
of	NULL
this	NULL
GATA	NULL
binding	NULL
site	NULL
by	NULL
a	NULL
canonical	NULL
TFIID	NULL
binding	NULL
site	NULL
suppresses	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

Mutations	NULL
and	NULL
deletions	NULL
of	NULL
both	NULL
sites	NULL
indicate	NULL
that	NULL
only	NULL
the	NULL
association	NULL
of	NULL
CCACC/Spl	NULL
and	NULL
GATA	NULL
binding	NULL
sites	NULL
can	NULL
drive	NULL
efficient	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
this	NULL
R-PK	NULL
minimal	NULL
promoter	NULL
.	NULL

Finally	NULL
,	NULL
by	NULL
co-transfection	NULL
experi-ments	NULL
,	NULL
we	NULL
study	NULL
the	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
hGATA-1	NULL
transactivation	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Pyruvate	NULL
kinase	NULL
(	NULL
ATP	NULL
:	NULL
pyruvate	NULL
2-O-phosphotransferase	NULL
,	NULL
EC	NULL
2.7.1.40	NULL
;	NULL
PK	NULL
)	NULL
,	NULL
a	NULL
key	NULL
enzyme	NULL
of	NULL
the	NULL
glycolytic	NULL
pathway	NULL
(	NULL
1	NULL
)	NULL
,	NULL
is	NULL
present	NULL
in	NULL
mammals	NULL
in	NULL
four	NULL
different	NULL
isozymic	NULL
forms	NULL
(	NULL
L	NULL
,	NULL
R	NULL
,	NULL
M	NULL
;	NULL
,	NULL
and	NULL
M	NULL
;	NULL
)	NULL
whose	NULL
expression	NULL
is	NULL
tissue-specific	NULL
(	NULL
2	NULL
)	NULL
.	NULL

These	NULL
isoforms	NULL
are	NULL
encoded	NULL
by	NULL
two	NULL
genes	NULL
.	NULL

The	NULL
M	NULL
gene	NULL
codes	NULL
for	NULL
the	NULL
M	NULL
;	NULL
-type	NULL
present	NULL
in	NULL
muscle	NULL
and	NULL
brain	NULL
and	NULL
for	NULL
the	NULL
M	NULL
;	NULL
-type	NULL
found	NULL
in	NULL
the	NULL
fetus	NULL
,	NULL
in	NULL
undifferentiated	NULL
tissues	NULL
,	NULL
and	NULL
in	NULL
most	NULL
adult	NULL
tissues	NULL
.	NULL

M	NULL
;	NULL
-	NULL
and	NULL
M-type	NULL
PK	NULL
are	NULL
generated	NULL
by	NULL
mRNAs	NULL
produced	NULL
after	NULL
alternative	NULL
splicing	NULL
of	NULL
the	NULL
same	NULL
primary	NULL
transcript	NULL
(	NULL
3	NULL
)	NULL
.	NULL

L-type	NULL
(	NULL
L-PK	NULL
)	NULL
and	NULL
R-type	NULL
(	NULL
R-PK	NULL
)	NULL
isoforms	NULL
are	NULL
also	NULL
encoded	NULL
by	NULL
a	NULL
single	NULL
gene	NULL
through	NULL
the	NULL
use	NULL
of	NULL
two	NULL
distinct	NULL
transcription	NULL
units	NULL
,	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
R-PK	NULL
being	NULL
situated	NULL
500	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
L-PK	NULL
(	NULL
4	NULL
)	NULL
.	NULL

L-PK	NULL
is	NULL
expressed	NULL
mainly	NULL
in	NULL
liver	NULL
but	NULL
also	NULL
in	NULL
gut	NULL
and	NULL
kidney	NULL
,	NULL
while	NULL
R-PK	NULL
is	NULL
specific	NULL
to	NULL
erythroid	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

During	NULL
erythroid	NULL
differentiation	NULL
,	NULL
immature	NULL
erythroblasts	NULL
express	NULL
R-PK	NULL
and	NULL
M	NULL
;	NULL
,	NULL
-PK	NULL
,	NULL
while	NULL
mature	NULL
erythrocytes	NULL
contain	NULL
only	NULL
R-PK	NULL
.	NULL

We	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
the	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
,	NULL
and	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
Supported	NULL
by	NULL
the	NULL
Ministére	NULL
de	NULL
la	NULL
Recherche	NULL
et	NULL
de	NULL
la	NULL
Santé	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PK	NULL
,	NULL
pyruvate	NULL
kinase	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
;	NULL
GpB	NULL
,	NULL
glycophorin	NULL
B.	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
determined	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
M	NULL
;	NULL
,	NULL
-PK	NULL
and	NULL
R-PK	NULL
during	NULL
the	NULL
maturation	NULL
of	NULL
erythroblasts	NULL
(	NULL
6-8	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
synthesis	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
two	NULL
isoenzymes	NULL
in	NULL
the	NULL
acquisition	NULL
of	NULL
the	NULL
PK	NULL
phenotype	NULL
of	NULL
mature	NULL
erythrocytes	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
rat	NULL
L-type	NULL
PK	NULL
gene	NULL
has	NULL
been	NULL
determined	NULL
(	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

This	NULL
gene	NULL
is	NULL
composed	NULL
of	NULL
12	NULL
exons	NULL
and	NULL
extends	NULL
over	NULL
9.3	NULL
kilobases	NULL
of	NULL
DNA	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
L-PK	NULL
in	NULL
liver	NULL
by	NULL
hormonal	NULL
and	NULL
nutritional	NULL
stimuli	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
DNA	NULL
elements	NULL
implicated	NULL
in	NULL
these	NULL
effects	NULL
and	NULL
in	NULL
liver	NULL
specificity	NULL
,	NULL
have	NULL
been	NULL
the	NULL
subject	NULL
of	NULL
numerous	NULL
studies	NULL
.	NULL

Four	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
described	NULL
in	NULL
a	NULL
proximal	NULL
promoter	NULL
:	NULL
two	NULL
of	NULL
them	NULL
bind	NULL
liver-specific	NULL
factors	NULL
(	NULL
the	NULL
hepatocyte	NULL
nuclear	NULL
factor	NULL
1	NULL
and	NULL
the	NULL
liver	NULL
factor	NULL
A1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
two	NULL
others	NULL
bind	NULL
ubiquitous	NULL
factors	NULL
(	NULL
the	NULL
nuclear	NULL
factor	NULL
1	NULL
and	NULL
the	NULL
major	NULL
late	NULL
transcription	NULL
factor	NULL
)	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

The	NULL
upstream	NULL
part	NULL
of	NULL
this	NULL
promoter	NULL
bears	NULL
a	NULL
carbohydrate	NULL
response	NULL
element	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
L-gene	NULL
has	NULL
also	NULL
been	NULL
studied	NULL
with	NULL
transgenic	NULL
mice	NULL
containing	NULL
either	NULL
the	NULL
entire	NULL
L-gene	NULL
(	NULL
19	NULL
)	NULL
or	NULL
a	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
L-PK	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Although	NULL
an	NULL
adequate	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
rat	NULL
L-type	NULL
PK	NULL
transcription	NULL
unit	NULL
was	NULL
repetitively	NULL
obtained	NULL
,	NULL
very	NULL
low	NULL
or	NULL
no	NULL
expression	NULL
from	NULL
the	NULL
rat	NULL
R-type	NULL
PK	NULL
transcription	NULL
unit	NULL
was	NULL
found	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
DNA	NULL
fragments	NULL
used	NULL
do	NULL
not	NULL
contain	NULL
all	NULL
the	NULL
DNA	NULL
sequences	NULL
necessary	NULL
for	NULL
erythroid-specific	NULL
expression	NULL
.	NULL

This	NULL
result	NULL
is	NULL
indeed	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
obtained	NULL
with	NULL
the	NULL
human	NULL
-globin	NULL
genes	NULL
.	NULL

In	NULL
transgenic	NULL
mice	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
B-globin	NULL
genes	NULL
is	NULL
low	NULL
unless	NULL
an	NULL
upstream	NULL
sequence	NULL
,	NULL
called	NULL
locus	NULL
control	NULL
region	NULL
is	NULL
present	NULL
(	NULL
21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
B-globin	NULL
promoter	NULL
elements	NULL
which	NULL
mediate	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
activity	NULL
have	NULL
been	NULL
determined	NULL
by	NULL
transfection	NULL
in	NULL
erythroid	NULL
cell	NULL
lines	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
results	NULL
prompt	NULL
us	NULL
to	NULL
study	NULL
whether	NULL
the	NULL
R-PK	NULL
promoter	NULL
could	NULL
display	NULL
erythroid	NULL
specificity	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
cis-	NULL
and	NULL
trans-acting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
define	NULL
by	NULL
deletion	NULL
experiments	NULL
a	NULL
core	NULL
promoter	NULL
sufficient	NULL
to	NULL
confer	NULL
erythroid-specific	NULL
expression	NULL
to	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
respective	NULL
involvement	NULL
of	NULL
the	NULL
different	NULL
sites	NULL
present	NULL
on	NULL
this	NULL
minimal	NULL
promoter	NULL
was	NULL
analyzed	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
GATA-1	NULL
and	NULL
TFIID	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
was	NULL
studied	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture-Two	NULL
human	NULL
erythroleukemic	NULL
cell	NULL
lines	NULL
,	NULL
K562	NULL
and	NULL
HEL	NULL
,	NULL
were	NULL
used	NULL
to	NULL
study	NULL
the	NULL
erythroid-specific	NULL
expression	NULL
.	NULL

K-562	NULL
was	NULL
established	NULL
from	NULL
the	NULL
pleural	NULL
effusion	NULL
of	NULL
a	NULL
53-year-old	NULL
female	NULL
with	NULL
chronic	NULL
myelocytic	NULL
leukemia	NULL
in	NULL
blast	NULL
crisis	NULL
(	NULL
23	NULL
)	NULL
,	NULL
whereas	NULL
HEL	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
a	NULL
28-year-old	NULL
male	NULL
with	NULL
Hodgkin	NULL
's	NULL
disease	NULL
who	NULL
later	NULL
developed	NULL
erythroleukemia	NULL
(	NULL
24	NULL
)	NULL
.	NULL

These	NULL
two	NULL
cell	NULL
lines	NULL
express	NULL
several	NULL
erythroid	NULL
markers	NULL
including	NULL
globins	NULL
and	NULL
R-PK	NULL
(	NULL
6	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Different	NULL
inducers	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
erythroid	NULL
markers	NULL
leading	NULL
to	NULL
an	NULL
5431	NULL
5432	NULL
increased	NULL
level	NULL
as	NULL
do	NULL
hemin	NULL
or	NULL
to	NULL
a	NULL
decreased	NULL
level	NULL
as	NULL
do	NULL
TPA	NULL
(	NULL
24-27	NULL
)	NULL
.	NULL

The	NULL
human	NULL
epithelial	NULL
cell	NULL
line	NULL
HeLa	NULL
was	NULL
used	NULL
as	NULL
a	NULL
nonerythroid	NULL
control	NULL
cell	NULL
line	NULL
.	NULL

K562	NULL
and	NULL
HEL	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
while	NULL
HeLa	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
,	NULL
each	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
mg/ml	NULL
streptomycin	NULL
.	NULL

Construction	NULL
of	NULL
Reporter	NULL
Plasmids-All	NULL
the	NULL
reporter	NULL
plasmids	NULL
were	NULL
constructed	NULL
by	NULL
insertion	NULL
(	NULL
5	NULL
HindIII	NULL
,	NULL
3	NULL
BamHI	NULL
)	NULL
of	NULL
the	NULL
DNA	NULL
fragments	NULL
of	NULL
interest	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
bacterial	NULL
coding	NULL
sequence	NULL
followed	NULL
by	NULL
the	NULL
t	NULL
intron	NULL
and	NULL
the	NULL
polyadenylation	NULL
signal	NULL
from	NULL
simian	NULL
virus	NULL
40	NULL
using	NULL
pBLCAT3	NULL
vector	NULL
(	NULL
28	NULL
)	NULL
.	NULL

pR-CAT	NULL
,	NULL
a	NULL
rat	NULL
genomic	NULL
clone	NULL
encoding	NULL
both	NULL
the	NULL
R-	NULL
and	NULL
L-type	NULL
PK	NULL
,	NULL
has	NULL
been	NULL
isolated	NULL
and	NULL
sequenced	NULL
(	NULL
4	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
spanning	NULL
nucleotides	NULL
-870	NULL
to	NULL
+54	NULL
relative	NULL
to	NULL
R-PK	NULL
cap	NULL
site	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
oligonucleotides	NULL
-870	NULL
and	NULL
+54	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
inserted	NULL
in	NULL
M13mp9	NULL
,	NULL
sequenced	NULL
,	NULL
and	NULL
subcloned	NULL
in	NULL
pBLCAT3	NULL
vector	NULL
.	NULL

Deleted	NULL
constructs	NULL
were	NULL
obtained	NULL
either	NULL
by	NULL
amplification	NULL
(	NULL
pA105R-CAT	NULL
:	NULL
oligonucleotides	NULL
-105	NULL
and	NULL
+54	NULL
,	NULL
pAGZ2R-CAT	NULL
:	NULL
oligonucleotides	NULL
-62	NULL
and	NULL
+54	NULL
)	NULL
or	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
pA256R-CAT	NULL
,	NULL
pA3OR-CAT	NULL
,	NULL
pA11R-CAT	NULL
)	NULL
:	NULL
the	NULL
-870	NULL
to	NULL
+54	NULL
region	NULL
subcloned	NULL
in	NULL
M13mp9	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
mutagenesis	NULL
using	NULL
the	NULL
Amersham	NULL
``	NULL
oligo-nucleotide-directed	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
system	NULL
.	NULL
``	NULL

Oligonucleotides	NULL
used	NULL
for	NULL
mutagenesis	NULL
created	NULL
a	NULL
HindIII	NULL
restriction	NULL
site	NULL
at	NULL
the	NULL
desired	NULL
location	NULL
.	NULL

The	NULL
HindlIII-BamHI	NULL
fragments	NULL
were	NULL
subsequently	NULL
subcloned	NULL
in	NULL
pBLCAT3	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
the	NULL
following	NULL
:	NULL
-870	NULL
,	NULL
55	NULL
TGCTAG-TAGTCTGTCCCCCA	NULL
3	NULL
``	NULL
;	NULL
+54	NULL
,	NULL
55	NULL
CTTCCAAAGCGTGGAACTGT	NULL
3	NULL
'	NULL
;	NULL
-105	NULL
,	NULL
5	NULL
GATGAAAGCTTCACAACAGGCAGTCCTTGA	NULL
3	NULL
'	NULL
;	NULL
-62	NULL
,	NULL
5	NULL
GATGAAAGCTTGGGGCTGCCTGCTGGGTGT	NULL
3	NULL
'	NULL
;	NULL
-256	NULL
,	NULL
5	NULL
'	NULL
ATTGAAGAGAAGCTTAGGTGTATT	NULL
3	NULL
;	NULL
-30	NULL
,	NULL
5	NULL
TTATCT-GAGGAAGCTTGAGAATAGAAA	NULL
3	NULL
``	NULL
;	NULL
-11	NULL
,	NULL
55	NULL
GTGTACCCTAAAA	NULL
GCTTGTCTTATCTG	NULL
3	NULL
'	NULL
.	NULL

Mutated	NULL
constructs	NULL
were	NULL
obtained	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
-62	NULL
to	NULL
+54	NULL
fragments	NULL
subcloned	NULL
in	NULL
M13mp9	NULL
as	NULL
templates	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
are	NULL
presented	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
.	NULL

All	NULL
the	NULL
constructs	NULL
were	NULL
sequenced	NULL
before	NULL
use	NULL
.	NULL

Construction	NULL
of	NULL
Expression	NULL
Vectors-Plasmids	NULL
that	NULL
constitutively	NULL
express	NULL
hGATA-1	NULL
and	NULL
PGAA	NULL
were	NULL
constructed	NULL
using	NULL
the	NULL
pECE	NULL
vector	NULL
(	NULL
29	NULL
)	NULL
where	NULL
the	NULL
inserted	NULL
cDNAs	NULL
are	NULL
transcriptionally	NULL
directed	NULL
by	NULL
the	NULL
SV40	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

An	NULL
EcoRI	NULL
DNA	NULL
fragment	NULL
containing	NULL
120	NULL
bp	NULL
of	NULL
the	NULL
5'-untranslated	NULL
region	NULL
,	NULL
the	NULL
complete	NULL
coding	NULL
region	NULL
,	NULL
as	NULL
well	NULL
as	NULL
60	NULL
bp	NULL
of	NULL
the	NULL
3	NULL
'	NULL
-untranslated	NULL
region	NULL
of	NULL
hGATA-1	NULL
was	NULL
inserted	NULL
at	NULL
the	NULL
unique	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
pECE	NULL
vector	NULL
(	NULL
pGATA-1	NULL
)	NULL
,	NULL
and	NULL
its	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
SV40	NULL
promoter/enhancer	NULL
was	NULL
checked	NULL
by	NULL
a	NULL
BamHI	NULL
digestion	NULL
.	NULL

pGAA	NULL
,	NULL
a	NULL
hGATA-1	NULL
mutant	NULL
that	NULL
contained	NULL
no	NULL
zinc	NULL
finger	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
an	NULL
Apal	NULL
digestion	NULL
of	NULL
hGATA-1	NULL
and	NULL
ligation	NULL
.	NULL

This	NULL
results	NULL
in	NULL
a	NULL
conserved	NULL
open	NULL
reading	NULL
frame	NULL
through	NULL
hGATA-1	NULL
but	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
two	NULL
zinc	NULL
fingers	NULL
.	NULL

PKB104	NULL
that	NULL
allows	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
TFIID	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
John	NULL
Ham	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
above-mentioned	NULL
fragment	NULL
of	NULL
hGATA-1	NULL
was	NULL
inserted	NULL
by	NULL
Xbal	NULL
,	NULL
Sall	NULL
in	NULL
pBluescript	NULL
II	NULL
SK-	NULL
(	NULL
pBS-GATA-1	NULL
)	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
hGATA-1	NULL
.	NULL

Transfection	NULL
Experiments-10	NULL
``	NULL
K562	NULL
,	NULL
HEL	NULL
,	NULL
or	NULL
HeLa	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
180	NULL
Ll	NULL
of	NULL
phosphate-buffered	NULL
saline-Hepes	NULL
(	NULL
10	NULL
mm	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
by	NULL
a	NULL
single	NULL
pulse	NULL
of	NULL
200	NULL
V	NULL
at	NULL
960	NULL
uF	NULL
with	NULL
a	NULL
Gene	NULL
Pulser	NULL
Apparatus	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
reporter	NULL
gene	NULL
plasmid	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
luciferase	NULL
plasmid	NULL
(	NULL
31	NULL
)	NULL
were	NULL
added	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
transactivation	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
GATA-1	NULL
expression	NULL
vector	NULL
(	NULL
pGATA-1	NULL
or	NULL
pGAA	NULL
)	NULL
was	NULL
also	NULL
added	NULL
.	NULL

Twenty	NULL
four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
lysed	NULL
in	NULL
100	NULL
Ll	NULL
of	NULL
250	NULL
mm	NULL
Tris	NULL
,	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
pH	NULL
7.8	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
assayed	NULL
by	NULL
measuring	NULL
conversion	NULL
of	NULL
[	NULL
``	NULL
*C	NULL
]	NULL
chloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
by	NULL
thin	NULL
layer	NULL
chromatog-raphy	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
acetylation	NULL
was	NULL
determined	NULL
by	NULL
cutting	NULL
out	NULL
the	NULL
silica	NULL
gel	NULL
pieces	NULL
corresponding	NULL
to	NULL
the	NULL
acetylated	NULL
and	NULL
nonacetylated	NULL
forms	NULL
and	NULL
counting	NULL
``	NULL
*C	NULL
radioactivity	NULL
.	NULL

Differences	NULL
in	NULL
transfection	NULL
efficiency	NULL
were	NULL
appreciated	NULL
by	NULL
the	NULL
co-transfection	NULL
of	NULL
RSVL	NULL
plasmid	NULL
and	NULL
determination	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
volumes	NULL
used	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
CAT	NULL
activity	NULL
were	NULL
in	NULL
inverse	NULL
ratio	NULL
to	NULL
the	NULL
luciferase	NULL
activity	NULL
.	NULL

When	NULL
the	NULL
effect	NULL
of	NULL
12-O-tetradecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
was	NULL
tested	NULL
,	NULL
a	NULL
double	NULL
amount	NULL
of	NULL
cells	NULL
was	NULL
electroporated	NULL
and	NULL
split	NULL
1	NULL
h	NULL
after	NULL
electroporation	NULL
.	NULL

TPA	NULL
was	NULL
added	NULL
to	NULL
one	NULL
half	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
16	NULL
nM	NULL
.	NULL

As	NULL
luciferase	NULL
expression	NULL
was	NULL
stimulated	NULL
by	NULL
TPA	NULL
R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
(	NULL
driven	NULL
by	NULL
Rous	NULL
sarcoma	NULL
virus-long	NULL
term	NULL
repeat	NULL
)	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
lysate	NULL
from	NULL
TPA-treated	NULL
samples	NULL
used	NULL
for	NULL
CAT	NULL
assay	NULL
was	NULL
adjusted	NULL
toward	NULL
that	NULL
of	NULL
the	NULL
control	NULL
samples	NULL
according	NULL
to	NULL
protein	NULL
concentration	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting	NULL
and	NULL
Gel	NULL
Shift	NULL
Assays-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
from	NULL
exponentially	NULL
growing	NULL
cells	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
)	NULL
using	NULL
an	NULL
amplified	NULL
fragment	NULL
that	NULL
spans	NULL
nucleotides	NULL
-229	NULL
to	NULL
+54	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
for	NULL
CCACC/Spl	NULL
and	NULL
GATA	NULL
proteins	NULL
from	NULL
nuclear	NULL
extracts	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
indicated	NULL
end-labeled	NULL
oligonucleotides	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
with	NULL
in	NULL
vitro-translated	NULL
TFIID	NULL
and	NULL
GATA	NULL
proteins	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

30	NULL
with	NULL
the	NULL
modification	NULL
that	NULL
no	NULL
nonspecific	NULL
competitor	NULL
was	NULL
added	NULL
.	NULL

In	NULL
Vitro	NULL
Transcriptions	NULL
and	NULL
Translations-In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
Promega	NULL
reagents	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
.	NULL

For	NULL
TFIID	NULL
transcription	NULL
,	NULL
pKB104	NULL
was	NULL
linearized	NULL
at	NULL
a	NULL
KpnI	NULL
site	NULL
downstream	NULL
of	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
and	NULL
transcribed	NULL
with	NULL
T	NULL
;	NULL
RNA	NULL
polymerase	NULL
.	NULL

For	NULL
hGATA-1	NULL
transcription	NULL
,	NULL
pBS-GATA-1	NULL
was	NULL
linearized	NULL
at	NULL
an	NULL
Xbal	NULL
site	NULL
and	NULL
transcribed	NULL
with	NULL
T7	NULL
RNA	NULL
polymerase	NULL
.	NULL

Translation	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
nu-clease-treated	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
an	NULL
amino	NULL
acid	NULL
mixture	NULL
containing	NULL
[	NULL
(	NULL
*S	NULL
)	NULL
methionine	NULL
so	NULL
as	NULL
to	NULL
label	NULL
the	NULL
synthesized	NULL
proteins	NULL
.	NULL

RESULTS	NULL
An	NULL
870-bp	NULL
DNA	NULL
Fragment	NULL
from	NULL
the	NULL
5	NULL
Region	NULL
of	NULL
the	NULL
R-PK	NULL
Gene	NULL
Confers	NULL
Erythroid	NULL
Specificity	NULL
to	NULL
a	NULL
Reporter	NULL
Gene-A	NULL
rat	NULL
genomic	NULL
clone	NULL
encoding	NULL
both	NULL
the	NULL
R-	NULL
and	NULL
L-type	NULL
PK	NULL
has	NULL
been	NULL
isolated	NULL
and	NULL
sequenced	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
published	NULL
sequence	NULL
,	NULL
we	NULL
amplified	NULL
a	NULL
924-bp	NULL
DNA	NULL
fragment	NULL
spanning	NULL
nucleotides	NULL
-870	NULL
to	NULL
+54	NULL
relative	NULL
to	NULL
the	NULL
R-PK	NULL
cap	NULL
site	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
sequenced	NULL
and	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
coding	NULL
sequence	NULL
in	NULL
the	NULL
vector	NULL
plasmid	NULL
pBLCAT3	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
was	NULL
called	NULL
pR-CAT	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
cellular	NULL
specificity	NULL
of	NULL
pR-CAT	NULL
expres-sion	NULL
,	NULL
this	NULL
plasmid	NULL
was	NULL
transiently	NULL
transfected	NULL
either	NULL
in	NULL
erythroid	NULL
(	NULL
K562	NULL
or	NULL
HEL	NULL
)	NULL
or	NULL
nonerythroid	NULL
(	NULL
HeLa	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
was	NULL
determined	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
compared	NULL
to	NULL
the	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
parental	NULL
vector	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
of	NULL
each	NULL
assay	NULL
was	NULL
taken	NULL
into	NULL
account	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
pR-CAT	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
parental	NULL
vector	NULL
one	NULL
in	NULL
HeLa	NULL
cells	NULL
while	NULL
it	NULL
was	NULL
,	NULL
respec-tively	NULL
,	NULL
18-	NULL
and	NULL
8-fold	NULL
higher	NULL
than	NULL
the	NULL
parental	NULL
vector	NULL
one	NULL
in	NULL
K562	NULL
and	NULL
HEL	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
also	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
TPA	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
pR-CAT	NULL
.	NULL

TPA	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
a	NULL
down-regulation	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
activity	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
is	NULL
partially	NULL
transcriptional	NULL
(	NULL
26	NULL
,	NULL
37	NULL
)	NULL
.	NULL

TPA	NULL
treatment	NULL
reduced	NULL
expression	NULL
nearly	NULL
8-fold	NULL
in	NULL
K562	NULL
cells	NULL
suggesting	NULL
that	NULL
this	NULL
DNA	NULL
fragment	NULL
contains	NULL
the	NULL
cis-acting	NULL
sequences	NULL
which	NULL
mediate	NULL
the	NULL
TPA	NULL
effect	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
Promoter	NULL
Region	NULL
of	NULL
R-PK	NULL
Gene	NULL
Contains	NULL
Multiple	NULL
Binding	NULL
Sites	NULL
for	NULL
Nuclear	NULL
Factors-To	NULL
map	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factors	NULL
,	NULL
a	NULL
DNA	NULL
fragment	NULL
spanning	NULL
nucleotide	NULL
-229	NULL
to	NULL
TABLE	NULL
I	NULL
Expression	NULL
of	NULL
a	NULL
R-PK	NULL
promoter	NULL
(	NULL
-870	NULL
to	NULL
+54	NULL
)	NULL
-CAT	NULL
construct	NULL
in	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cell	NULL
lines	NULL
pRCAT	NULL
was	NULL
transfected	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
as	NULL
indicated	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

CAT	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
rate	NULL
of	NULL
acetylation	NULL
obtained	NULL
from	NULL
pR-CAT	NULL
plasmid	NULL
versus	NULL
the	NULL
rate	NULL
obtained	NULL
from	NULL
the	NULL
promoter-less	NULL
control	NULL
plasmid	NULL
(	NULL
pBL-CAT3	NULL
)	NULL
taking	NULL
into	NULL
account	NULL
the	NULL
transfection	NULL
efficiency	NULL
of	NULL
each	NULL
experiment	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
data	NULL
are	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Cell	NULL
line	NULL
CAT	NULL
activity	NULL
K562	NULL
18	NULL
+	NULL
1.1	NULL
K562	NULL
+	NULL
TPA	NULL
2.4	NULL
+	NULL
0.6	NULL
HEL	NULL
8	NULL
+	NULL
2.3	NULL
Hela	NULL
1	NULL
+	NULL
0.2	NULL
R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
+54	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
was	NULL
analyzed	NULL
by	NULL
DNase	NULL
I	NULL
footprint-ing	NULL
.	NULL

Five	NULL
protected	NULL
sequences	NULL
were	NULL
found	NULL
:	NULL
three	NULL
of	NULL
them	NULL
(	NULL
A	NULL
,	NULL
D	NULL
,	NULL
E	NULL
)	NULL
were	NULL
strongly	NULL
protected	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
erythroid	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Region	NULL
E	NULL
was	NULL
also	NULL
weakly	NULL
protected	NULL
by	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Regions	NULL
B	NULL
and	NULL
C	NULL
were	NULL
protected	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
erythroid	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
and	NULL
nonerythroid	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

A	NULL
map	NULL
of	NULL
the	NULL
different	NULL
footprints	NULL
as	NULL
they	NULL
occur	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
erythroid	NULL
nuclear	NULL
extract	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

A	NULL
DNA	NULL
Fragment	NULL
Spanning	NULL
Nucleotides	NULL
-62	NULL
to	NULL
+54	NULL
of	NULL
the	NULL
R-PK	NULL
Gene	NULL
Is	NULL
Sufficient	NULL
for	NULL
Erythroid-specific	NULL
Activity-To	NULL
determine	NULL
the	NULL
function	NULL
of	NULL
the	NULL
different	NULL
DNA	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
erythroid-specific	NULL
activity	NULL
of	NULL
R-PK	NULL
promoter	NULL
,	NULL
a	NULL
set	NULL
of	NULL
deletion	NULL
mutants	NULL
was	NULL
constructed	NULL
and	NULL
tested	NULL
in	NULL
transient	NULL
transfection	NULL
assay	NULL
in	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
all	NULL
the	NULL
mutants	NULL
tested	NULL
were	NULL
completely	NULL
inactive	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
erythroid	NULL
cells	NULL
,	NULL
similar	NULL
activities	NULL
were	NULL
obtained	NULL
with	NULL
pA62R-CAT	NULL
,	NULL
pA105R-CAT	NULL
,	NULL
and	NULL
pR-CAT	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
minimal	NULL
promoter	NULL
of	NULL
62	NULL
bases	NULL
was	NULL
sufficient	NULL
for	NULL
erythroid-specific	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
TPA	NULL
,	NULL
there	NULL
was	NULL
no	NULL
more	NULL
expression	NULL
of	NULL
pA105R-CAT	NULL
and	NULL
pA62R-CAT	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
showing	NULL
that	NULL
these	NULL
two	NULL
constructs	NULL
contained	NULL
DNA	NULL
sequences	NULL
mediating	NULL
the	NULL
TPA	NULL
effect	NULL
.	NULL

Mutant	NULL
pA256R-CAT	NULL
gave	NULL
a	NULL
low	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
suggesting	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
silencer	NULL
element	NULL
between	NULL
-256	NULL
and	NULL
-105	NULL
.	NULL

This	NULL
silencer	NULL
was	NULL
not	NULL
studied	NULL
further	NULL
.	NULL

Promoters	NULL
smaller	NULL
than	NULL
pA62R-CAT	NULL
have	NULL
a	NULL
very	NULL
low	NULL
(	NULL
pA30R-CAT	NULL
)	NULL
or	NULL
no	NULL
CAT	NULL
activity	NULL
at	NULL
all	NULL
(	NULL
pA1lR-CAT	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
pA62R-CAT	NULL
was	NULL
studied	NULL
further	NULL
as	NULL
the	NULL
minimal	NULL
promoter	NULL
that	NULL
displayed	NULL
erythroid-specific	NULL
activity	NULL
.	NULL

GATA	NULL
and	NULL
CCACC	NULL
Proteins	NULL
Bind	NULL
the	NULL
-62	NULL
to	NULL
+54	NULL
DNA	NULL
Fragment-To	NULL
further	NULL
analyze	NULL
the	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
-62	NULL
to	NULL
+54	NULL
DNA	NULL
fragment	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
oligonucleotides	NULL
containing	NULL
sites	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Site	NULL
A	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
contains	NULL
a	NULL
potential	NULL
binding	NULL
site	NULL
(	NULL
5	NULL
AGATAA	NULL
3	NULL
``	NULL
)	NULL
for	NULL
a	NULL
GATA	NULL
protein	NULL
.	NULL

Using	NULL
an	NULL
oligonucleotide	NULL
encompassing	NULL
this	NULL
sequence	NULL
,	NULL
a	NULL
specific	NULL
complex	NULL
was	NULL
ob	NULL
+229	NULL
GAAAGGCATTGTACTGTTGGCAATCAACCAATC	NULL
E.	NULL
TCTTCTCTAATGATGAGCCAACAATGTGAATGGA	NULL
CTAATGATIGATCAGGAAAAAATAGATGACCTAG	NULL
D	NULL
GGGAAGGGGAGAGATGGGGGCCCCACAACAGGCAG	NULL
TCCTTGAGAAGGGACTCTGTGGGGATGGGGCTGC	NULL
CTGCTGGGTGTGCCCCTTTITCTATICICTGGCTT	NULL
CCTCAGATAAGACCAGCAGTTAGGGTACACTCTCC	NULL
A	NULL
TCCCAGTCTGCCGTTCTTGCAGACACAGTTCCACG	NULL
CTTTGGAAG	NULL
+34	NULL
1	NULL
2	NULL
3	NULL
48	NULL
coding	NULL
strand	NULL
1	NULL
23	NULL
45	NULL
Non	NULL
coding	NULL
strand	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
the	NULL
-229	NULL
to	NULL
+54	NULL
promoter	NULL
fragment	NULL
was	NULL
*P	NULL
either	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
or	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
,	NULL
incubated	NULL
with	NULL
no	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
HeLa	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
HEL	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
.	NULL

Lane	NULL
I	NULL
is	NULL
a	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
depurination	NULL
of	NULL
the	NULL
same	NULL
fragment	NULL
.	NULL

The	NULL
regions	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
are	NULL
indicated	NULL
by	NULL
lines	NULL
.	NULL

B	NULL
,	NULL
map	NULL
of	NULL
the	NULL
protected	NULL
regions	NULL
deduced	NULL
from	NULL
DNase	NULL
I	NULL
footprint	NULL
.	NULL

The	NULL
regions	NULL
protected	NULL
only	NULL
by	NULL
erythroid	NULL
extracts	NULL
are	NULL
underlined	NULL
with	NULL
continuous	NULL
lines	NULL
while	NULL
the	NULL
regions	NULL
protected	NULL
by	NULL
erythroid	NULL
or	NULL
nonerythroid	NULL
nuclear	NULL
extracts	NULL
are	NULL
underlined	NULL
with	NULL
dotted	NULL
lines	NULL
.	NULL

5433	NULL
served	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HEL	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
the	NULL
complexes	NULL
obtained	NULL
with	NULL
site	NULL
A	NULL
oligonucleotide	NULL
and	NULL
the	NULL
already	NULL
known	NULL
GATA	NULL
site	NULL
of	NULL
glycophorin	NULL
B	NULL
(	NULL
GpB	NULL
)	NULL
was	NULL
similar	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Site	NULL
A	NULL
binding	NULL
was	NULL
impaired	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
site	NULL
A	NULL
or	NULL
GpB	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
while	NULL
unlabeled	NULL
site	NULL
A	NULL
oligonucleotide	NULL
impaired	NULL
GpB	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
the	NULL
specific	NULL
GATA	NULL
binding	NULL
of	NULL
site	NULL
A	NULL
.	NULL

Site	NULL
B	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
matches	NULL
the	NULL
CCACC/Sp1	NULL
binding	NULL
sequence	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
HEL	NULL
nuclear	NULL
extracts	NULL
,	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
with	NULL
a	NULL
5'-end-labeled	NULL
oligonucleotide	NULL
containing	NULL
site	NULL
B	NULL
showed	NULL
complexes	NULL
reminiscent	NULL
of	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
CCACC	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
3-globin	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
part	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
present	NULL
when	NULL
a	NULL
Spl	NULL
binding	NULL
sequence	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
encompassing	NULL
the	NULL
/3-globin	NULL
CCACC	NULL
sequence	NULL
or	NULL
the	NULL
site	NULL
B	NULL
sequence	NULL
entailed	NULL
a	NULL
complete	NULL
disappearance	NULL
of	NULL
the	NULL
complexes	NULL
previously	NULL
obtained	NULL
with	NULL
site	NULL
B	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
while	NULL
a	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
Spl	NULL
binding	NULL
oligonucleotide	NULL
allowed	NULL
the	NULL
persistence	NULL
of	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
indicating	NULL
its	NULL
specificity	NULL
as	NULL
a	NULL
CCACC	NULL
binding	NULL
complex	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
site	NULL
B	NULL
could	NULL
bind	NULL
members	NULL
of	NULL
the	NULL
CCACC/Sp1	NULL
family	NULL
.	NULL

CCACC	NULL
and	NULL
Sp1	NULL
Binding	NULL
Sites	NULL
Allow	NULL
the	NULL
Erythroid-specific	NULL
Activity	NULL
of	NULL
the	NULL
R-PK	NULL
Promoter-As	NULL
one	NULL
complex	NULL
was	NULL
specific	NULL
to	NULL
the	NULL
CCACC	NULL
binding	NULL
proteins	NULL
,	NULL
we	NULL
could	NULL
design	NULL
a	NULL
mutated	NULL
oligonucleotide	NULL
(	NULL
mutant	NULL
1	NULL
,	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
which	NULL
could	NULL
bind	NULL
Sp1	NULL
but	NULL
not	NULL
CCACC	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
oligonucleotide	NULL
was	NULL
used	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
pA62R-CAT	NULL
,	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
resulting	NULL
mutant	NULL
promoter	NULL
(	NULL
pA62R-CATmutl	NULL
)	NULL
was	NULL
investigated	NULL
by	NULL
transient	NULL
transfection	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
,	NULL
pA62R-CATmutl1	NULL
activity	NULL
was	NULL
60	NULL
%	NULL
of	NULL
pAG2R-CAT	NULL
activity	NULL
in	NULL
erythroid	NULL
cell	NULL
lines	NULL
.	NULL

There	NULL
was	NULL
no	NULL
expression	NULL
of	NULL
pA62R-CATmut1	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
Sp1	NULL
and	NULL
CCACC	NULL
binding	NULL
allow	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
,	NULL
although	NULL
the	NULL
CCACC	NULL
binding	NULL
seems	NULL
more	NULL
efficient	NULL
.	NULL

The	NULL
GATA	NULL
Binding	NULL
Site	NULL
Is	NULL
Necessary	NULL
for	NULL
the	NULL
Erythroid-specific	NULL
Activity	NULL
of	NULL
the	NULL
R-PK	NULL
Promoter-The	NULL
position	NULL
(	NULL
-20	NULL
)	NULL
and	NULL
sequence	NULL
of	NULL
the	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
5	NULL
AGATAA	NULL
3	NULL
``	NULL
)	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
prompted	NULL
us	NULL
to	NULL
consider	NULL
a	NULL
possible	NULL
overlap	NULL
between	NULL
a	NULL
GATA	NULL
and	NULL
a	NULL
TFIID	NULL
binding	NULL
site	NULL
.	NULL

First	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
,	NULL
by	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
human	NULL
TFIID	NULL
and	NULL
GATA-1	NULL
on	NULL
oligonucleotides	NULL
bearing	NULL
the	NULL
R-PK	NULL
GATA	NULL
site	NULL
and	NULL
the	NULL
E1B	NULL
TATA	NULL
box	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
translated	NULL
hTFIID	NULL
and	NULL
hGATA-1	NULL
were	NULL
present	NULL
at	NULL
the	NULL
expected	NULL
molecular	NULL
weight	NULL
on	NULL
SDS-acrylamide	NULL
electro-phoresis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
a	NULL
reticulocyte	NULL
lysate	NULL
without	NULL
exogenously	NULL
added	NULL
RNA	NULL
was	NULL
used	NULL
,	NULL
a	NULL
nonspecific	NULL
band	NULL
was	NULL
seen	NULL
with	NULL
all	NULL
probes	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
specific	NULL
binding	NULL
of	NULL
GATA-1	NULL
on	NULL
GATA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
which	NULL
was	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
GATA	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
there	NULL
was	NULL
a	NULL
binding	NULL
of	NULL
hTFIID	NULL
on	NULL
the	NULL
E1B	NULL
TATA	NULL
box	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
which	NULL
was	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
E1B	NULL
TATA	NULL
box	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
hGATA-1	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
E1B	NULL
TATA	NULL
box	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
hTFIID	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
-20	NULL
R-PK	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
translation	NULL
of	NULL
hTFIID	NULL
and	NULL
hGATA-1	NULL
by	NULL
the	NULL
same	NULL
reticulocyte	NULL
lysate	NULL
,	NULL
there	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
mobility	NULL
shift	NULL
indicating	NULL
no	NULL
stable	NULL
association	NULL
of	NULL
the	NULL
two	NULL
factors	NULL
on	NULL
either	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
.	NULL

5434	NULL
R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
CONSTRUCTS	NULL
CAT	NULL
ACTIVITY	NULL
K562	NULL
HEL	NULL
Hela	NULL
TPA	NULL
-	NULL
TPA	NULL
+	NULL
pR-CAT	NULL
-	NULL
810	NULL
-210	NULL
-160	NULL
-80	NULL
-	NULL
-50	NULL
0-20	NULL
_	NULL
+34	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
5	NULL
'	NULL
deletions	NULL
on	NULL
y	NULL
®	NULL
I8+11	NULL
-	NULL
24to6	NULL
|	NULL
s+23	NULL
|	NULL
1+02	NULL
the	NULL
R-PK	NULL
promoter	NULL
activity	NULL
in	NULL
C	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
three	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
pAZSGR'gﬁ	NULL
:	NULL
transfected	NULL
with	NULL
the	NULL
different	NULL
constructs	NULL
'	NULL
'	NULL
.	NULL

wees	NULL
CAT	NULL
0.5+0.1	NULL
__	NULL
ND	NULL
.	NULL

1+0.1	NULL
|	NULL
i+oa	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Pro-	NULL
cedures	NULL
.	NULL
``	NULL

The	NULL
protected	NULL
sites	NULL
determined	NULL
pAIOSR-CAT	NULL
on	NULL
Fig	NULL
.	NULL

1	NULL
are	NULL
represented	NULL
on	NULL
each	NULL
deleted	NULL
-105	NULL
construct	NULL
-	NULL
scheme	NULL
,	NULL
-	NULL
erythroid-specific	NULL
11+27	NULL
-	NULL
itoa	NULL
|	NULL
1rti2	NULL
|	NULL
1f02	NULL
sites	NULL
being	NULL
indicated	NULL
by	NULL
black	NULL
boxes	NULL
and	NULL
ubiquitous	NULL
sites	NULL
being	NULL
indicated	NULL
by	NULL
pA6ZR-CAT	NULL
hatched	NULL
boxes	NULL
.	NULL

CAT	NULL
activity	NULL
is	NULL
expressed	NULL
-	NULL
62	NULL
R	NULL
R	NULL
R	NULL
as	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
data	NULL
are	NULL
means	NULL
+	NULL
S.	NULL
1614.3	NULL
-	NULL
0.5t0.1	NULL
|	NULL
11.5t2.1	NULL
|	NULL
1.6204	NULL
D.	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

N.D.	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

pA3OR-CAT	NULL
-	NULL
30	NULL
Car	NULL
]	NULL
|17+05	NULL
_	NULL
ND	NULL
.	NULL

3a2t1	NULL
|	NULL
18t0.s	NULL
pALR-CAT	NULL
-~11	NULL
110.3	NULL
N.D.	NULL
1.2	NULL
+0.3	NULL
1	NULL
+0.2	NULL
A	NULL
B	NULL
A	NULL
B	NULL
HEL	NULL
nuclear	NULL
extract	NULL
HEL	NULL
nuclear	NULL
extract	NULL
P	NULL
%	NULL
3	NULL
4	NULL
§	NULL
67	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
B	NULL
(	NULL
Site	NULL
B	NULL
)	NULL
5	NULL
'	NULL
TGCTGGemeTeccccTTrTcTATT	NULL
3	NULL
A	NULL
(	NULL
Site	NULL
A	NULL
)	NULL
:	NULL
§|	NULL
{	NULL
-	NULL
>	NULL
5	NULL
``	NULL
CTGGCTTCCTCAGATAAGACCAGCAGT	NULL
3	NULL
'	NULL
€	NULL
(	NULL
Mutant	NULL
1	NULL
)	NULL
oP	NULL
&	NULL
``	NULL
I	NULL
a	NULL
,	NULL
--	NULL
CACC	NULL
-	NULL
>	NULL
5°	NULL
TGCTGGGCTGTAcccTTTrctAT	NULL
?	NULL

3	NULL
2	NULL
(	NULL
Mutant	NULL
2	NULL
)	NULL
:	NULL
5	NULL
``	NULL
CTGGCTTCCTCACCGAAGACCAGCAGT	NULL
3	NULL
'	NULL
c	NULL
(	NULL
cace	NULL
)	NULL
5	NULL
'	NULL
GTGGAGCCACACCCTAGGGTT	NULL
3°	NULL
3	NULL
(	NULL
Mutant	NULL
3	NULL
)	NULL
:	NULL
5	NULL
``	NULL
CTGGCTTCCTCATATAAGACCAGCAGT	NULL
3	NULL
'	NULL
8	NULL
(	NULL
Spl	NULL
)	NULL
5°	NULL
CGCAGAGGGGCGGGCCTGG	NULL
3	NULL
'	NULL
F	NULL
-m	NULL
»	NULL
C.	NULL
Competitor	NULL
«	NULL
0+	NULL
+	NULL
.	NULL

C	NULL
8	NULL
B	NULL
5	NULL
``	NULL
TGGGCCTGGAAGATAACAGCTAGTA	NULL
3	NULL
'	NULL
*a	NULL
{	NULL
iss	NULL
}	NULL
F	NULL
-	NULL
>	NULL
Probe	NULL
B	NULL
J	NULL
C	NULL
S00	NULL
B	NULL
Competitor	NULL
-	NULL
A	NULL
-	NULL
A	NULL
G3	NULL
.	NULL

>	NULL
L__L	NULL
___	NULL
LL	NULL
]	NULL
Probe	NULL
G	NULL
A	NULL
2	NULL
3	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assay	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
site	NULL
A	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HEL	NULL
nuclear	NULL
extract	NULL
.	NULL

A	NULL
,	NULL
sequences	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
studied	NULL
oligonucleotides	NULL
.	NULL

Oligonucleotides	NULL
spanning	NULL
the	NULL
footprinted	NULL
site	NULL
A	NULL
(	NULL
nucleotides	NULL
-36	NULL
to	NULL
-6	NULL
)	NULL
,	NULL
two	NULL
mutations	NULL
of	NULL
site	NULL
A	NULL
,	NULL
and	NULL
a	NULL
GATA	NULL
site	NULL
from	NULL
the	NULL
human	NULL
GpB	NULL
promoter	NULL
(	NULL
nucleotides	NULL
-51	NULL
to	NULL
-27	NULL
)	NULL
were	NULL
studied	NULL
.	NULL

Bold	NULL
letters	NULL
indicated	NULL
the	NULL
GATA	NULL
motif	NULL
of	NULL
site	NULL
A	NULL
oligonucleotide	NULL
and	NULL
its	NULL
mutated	NULL
derivatives	NULL
on	NULL
mutant	NULL
2	NULL
and	NULL
mutant	NULL
3	NULL
oligonucleotides	NULL
.	NULL

B	NULL
,	NULL
0.2	NULL
ng	NULL
of	NULL
double-stranded	NULL
*P-end-labeled	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
HEL	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4-6	NULL
)	NULL
of	NULL
100	NULL
ng	NULL
of	NULL
a	NULL
competitor	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

At	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
,	NULL
the	NULL
probe	NULL
and	NULL
competitor	NULL
used	NULL
are	NULL
indicated	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
free	NULL
probes	NULL
(	NULL
F	NULL
)	NULL
and	NULL
the	NULL
specific	NULL
complexes	NULL
(	NULL
B	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
the	NULL
-20	NULL
GATA	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
R-PK	NULL
promoter	NULL
function	NULL
,	NULL
two	NULL
mutants	NULL
of	NULL
site	NULL
A	NULL
were	NULL
studied	NULL
.	NULL

Mutant	NULL
2	NULL
bears	NULL
a	NULL
GAT	NULL
-	NULL
CCG	NULL
mutation	NULL
at	NULL
position	NULL
-20	NULL
,	NULL
while	NULL
mutant	NULL
3	NULL
bears	NULL
a	NULL
G	NULL
-	NULL
T	NULL
mutation	NULL
at	NULL
position	NULL
-20	NULL
in	NULL
site	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

34A	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
mutated	NULL
oligonucleotides	NULL
were	NULL
checked	NULL
in	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
.	NULL

None	NULL
of	NULL
these	NULL
two	NULL
mutants	NULL
bound	NULL
GATA	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
or	NULL
competed	NULL
with	NULL
GATA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
complex	NULL
between	NULL
mutant	NULL
3	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assay	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
site	NULL
B	NULL
in	NULL
presence	NULL
of	NULL
HEL	NULL
nuclear	NULL
extract	NULL
.	NULL

A	NULL
,	NULL
sequences	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
studied	NULL
oligonucleotides	NULL
.	NULL

Four	NULL
oligonucleotides	NULL
spanning	NULL
the	NULL
footprinted	NULL
site	NULL
B	NULL
(	NULL
nucleotides	NULL
-58	NULL
to	NULL
-35	NULL
)	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
B	NULL
,	NULL
a	NULL
CCACC	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
human	NULL
$	NULL
-globin	NULL
promoter	NULL
(	NULL
nucleotides	NULL
-99	NULL
to	NULL
-79	NULL
)	NULL
,	NULL
and	NULL
a	NULL
specific	NULL
Spl	NULL
binding	NULL
site	NULL
were	NULL
studied	NULL
.	NULL

Bold	NULL
letters	NULL
indicated	NULL
the	NULL
bases	NULL
concerned	NULL
with	NULL
the	NULL
mutation	NULL
of	NULL
site	NULL
B	NULL
.	NULL

B	NULL
,	NULL
0.2	NULL
ng	NULL
of	NULL
double-stranded	NULL
*P-end-labeled	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
HEL	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
of	NULL
100	NULL
ng	NULL
of	NULL
a	NULL
competitor	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

At	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
,	NULL
the	NULL
probe	NULL
and	NULL
competitor	NULL
used	NULL
are	NULL
indicated	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
free	NULL
probes	NULL
(	NULL
F	NULL
)	NULL
and	NULL
the	NULL
specific	NULL
complexes	NULL
(	NULL
Sp1	NULL
and	NULL
CCACC	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

oligonucleotide	NULL
and	NULL
TFIID	NULL
protein	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
which	NULL
was	NULL
competed	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
E1B	NULL
TATA	NULL
box	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

These	NULL
two	NULL
oligonucleotides	NULL
were	NULL
used	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
pA62R-CAT	NULL
construct	NULL
,	NULL
and	NULL
the	NULL
two	NULL
mutated	NULL
promoters	NULL
were	NULL
studied	NULL
by	NULL
transient	NULL
transfection	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Mutations	NULL
2	NULL
and	NULL
3	NULL
abolished	NULL
CAT	NULL
activity	NULL
in	NULL
erythroid	NULL
cells	NULL
while	NULL
they	NULL
did	NULL
not	NULL
allow	NULL
the	NULL
promoter	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
GATA-1	NULL
and	NULL
TFIID	NULL
are	NULL
not	NULL
mutual	NULL
substitutes	NULL
as	NULL
DNA	NULL
binding	NULL
factor	NULL
on	NULL
the	NULL
-20	NULL
GATA	NULL
sequence	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
.	NULL

Transactivation	NULL
by	NULL
hGATA-1	NULL
Allows	NULL
Activity	NULL
of	NULL
the	NULL
R-PK	NULL
R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
TABLE	NULL
II	NULL
Effect	NULL
of	NULL
point	NULL
mutations	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
pA62R-CAT	NULL
in	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cell	NULL
lines	NULL
K562	NULL
,	NULL
HEL	NULL
,	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
different	NULL
construct	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

CAT	NULL
activity	NULL
was	NULL
expressed	NULL
as	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
data	NULL
are	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Mutation	NULL
1	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
B	NULL
abolishing	NULL
CCACC	NULL
binding	NULL
,	NULL
is	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Mutation	NULL
2	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
A	NULL
abolishing	NULL
GATA	NULL
binding	NULL
,	NULL
and	NULL
mutation	NULL
3	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
A	NULL
creating	NULL
a	NULL
TATA	NULL
motif	NULL
,	NULL
are	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

CAT	NULL
activity	NULL
Construct	NULL
once	NULL
.	NULL

g	NULL
K562	NULL
HEL	NULL
HeLa	NULL
e	NULL
PA62R-CAT	NULL
16	NULL
+	NULL
4.3	NULL
11.5	NULL
%	NULL
2.1	NULL
1.6	NULL
+	NULL
0.4	NULL
PA62R-CATmut1	NULL
9.8	NULL
£	NULL
0.2	NULL
7.5	NULL
%	NULL
2.5	NULL
1.1	NULL
£	NULL
0.2	NULL
PA62R-CAT	NULL
mut2	NULL
0.6	NULL
+	NULL
0.2	NULL
1.2	NULL
%	NULL
0.1	NULL
1	NULL
%	NULL
0.1	NULL
PA62R-CAT	NULL
mut3	NULL
1.9	NULL
+	NULL
0.6	NULL
1.5	NULL
£	NULL
0.5	NULL
2	NULL
£	NULL
0.6	NULL
GATAL	NULL
-	NULL
4	NULL
-	NULL
4	NULL
4	NULL
-	NULL
%	NULL
-	NULL
$	NULL
4	NULL
..	NULL
TFIID	NULL
to	NULL
t	NULL
tot	NULL
+	NULL
o	NULL
>	NULL
~	NULL
tot	NULL
4+	NULL
+	NULL
TFIID	NULL
C000	NULL
a	NULL
uu	NULL
GATA	NULL
-	NULL
>	NULL
(	NULL
we	NULL
is	NULL
NS	NULL
-	NULL
>	NULL
F	NULL
-	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1112	NULL
Competitor	NULL
_	NULL
~	NULL
-	NULL
=	NULL
>	NULL
0S	NULL
.	NULL

>	NULL
o	NULL
>	NULL
>	NULL
”	NULL
3	NULL
&	NULL
0	NULL
?	NULL

=	NULL
L	NULL
I	NULL
1	NULL
J	NULL
Probe	NULL
GATA	NULL
TATA	NULL
Mut3	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assay	NULL
of	NULL
GATA	NULL
and	NULL
TATA	NULL
motifs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
in	NULL
vitro-translated	NULL
hTFIID	NULL
and	NULL
hGATA-1	NULL
proteins	NULL
.	NULL

The	NULL
double-stranded	NULL
*P-end-labeled	NULL
E1B	NULL
adenovirus	NULL
TATA	NULL
box	NULL
(	NULL
TATA	NULL
)	NULL
,	NULL
R-PK	NULL
promoter	NULL
site	NULL
A	NULL
(	NULL
GATA	NULL
)	NULL
,	NULL
and	NULL
mutated	NULL
site	NULL
A	NULL
(	NULL
Mut3	NULL
)	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
programmed	NULL
with	NULL
RNA	NULL
from	NULL
pKB104	NULL
(	NULL
TFIID	NULL
)	NULL
,	NULL
pBS-GATA-1	NULL
(	NULL
GATA-1	NULL
)	NULL
,	NULL
both	NULL
,	NULL
or	NULL
with	NULL
no	NULL
exogenously	NULL
added	NULL
RNA	NULL
(	NULL
-	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
E1B	NULL
oligonucleotide	NULL
is	NULL
GACTTAAAGGGTATATAATGCGCCGTG	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
coding	NULL
strands	NULL
of	NULL
site	NULL
A	NULL
(	NULL
nucleotides	NULL
-36	NULL
to	NULL
-6	NULL
)	NULL
and	NULL
mutant	NULL
3	NULL
(	NULL
AGATAA	NULL
-	NULL
>	NULL
ATATAA	NULL
)	NULL
oligonucleotides	NULL
are	NULL
presented	NULL
on	NULL
Fig	NULL
.	NULL

3A	NULL
.	NULL

For	NULL
each	NULL
lane	NULL
,	NULL
the	NULL
used	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
and	NULL
competitor	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
proteins	NULL
added	NULL
(	NULL
2.5	NULL
ul	NULL
)	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

The	NULL
free	NULL
probes	NULL
(	NULL
F	NULL
)	NULL
,	NULL
the	NULL
nonspecific	NULL
complexes	NULL
(	NULL
NS	NULL
)	NULL
,	NULL
and	NULL
the	NULL
specific	NULL
complexes	NULL
(	NULL
TFIID	NULL
and	NULL
GATA	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Promoter	NULL
in	NULL
a	NULL
Nonerythroid	NULL
Cell	NULL
Line-As	NULL
the	NULL
R-PK	NULL
promoter	NULL
was	NULL
inactive	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
active	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
we	NULL
studied	NULL
its	NULL
possible	NULL
transactivation	NULL
by	NULL
hGATA-1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
III	NULL
,	NULL
all	NULL
the	NULL
constructs	NULL
containing	NULL
a	NULL
GATA	NULL
binding	NULL
site	NULL
were	NULL
transactivated	NULL
2-	NULL
to	NULL
3-fold	NULL
,	NULL
and	NULL
the	NULL
constructs	NULL
lacking	NULL
the	NULL
GATA	NULL
binding	NULL
site	NULL
were	NULL
not	NULL
transactivated	NULL
.	NULL

However	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
similar	NULL
results	NULL
obtained	NULL
for	NULL
the	NULL
transactivation	NULL
of	NULL
pAG2R-CAT	NULL
and	NULL
pA30R-CAT	NULL
,	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
CCACC/Sp1	NULL
binding	NULL
site	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
hGATA-1-mediated	NULL
transactivation	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
contrasts	NULL
with	NULL
the	NULL
sequence	NULL
requirement	NULL
for	NULL
an	NULL
efficient	NULL
activity	NULL
of	NULL
the	NULL
R-PK	NULL
promoter	NULL
in	NULL
erythroid	NULL
cells	NULL
and	NULL
indicates	NULL
that	NULL
transactivation	NULL
in	NULL
HeLa	NULL
cells	NULL
might	NULL
not	NULL
completely	NULL
mimic	NULL
the	NULL
mechanisms	NULL
that	NULL
underlie	NULL
the	NULL
erythroid	NULL
specificity	NULL
of	NULL
the	NULL
pA62R-CAT	NULL
construct	NULL
.	NULL

5435	NULL
TABLE	NULL
III	NULL
Transactivation	NULL
by	NULL
hGATA-1	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
pGATA-1	NULL
or	NULL
pGAA	NULL
associated	NULL
to	NULL
the	NULL
mentioned	NULL
constructs	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
pA62R-CAT	NULL
,	NULL
pA30R-CAT	NULL
,	NULL
and	NULL
pA11R-CAT	NULL
is	NULL
on	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Mutation	NULL
1	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
B	NULL
abolishing	NULL
CCACC	NULL
binding	NULL
,	NULL
is	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Mutation	NULL
2	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
A	NULL
abolishing	NULL
GATA	NULL
binding	NULL
,	NULL
and	NULL
mutation	NULL
3	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
site	NULL
A	NULL
creating	NULL
a	NULL
TATA	NULL
motif	NULL
,	NULL
are	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
Table	NULL
I.	NULL
Transactivation	NULL
was	NULL
calculated	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pGATA-1	NULL
on	NULL
CAT	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pGAA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

Construct	NULL
Rate	NULL
of	NULL
transactivation	NULL
PAG62R-CAT	NULL
2.5	NULL
£	NULL
0.6	NULL
PA3OR-CAT	NULL
2.1	NULL
%	NULL
0.6	NULL
PA1IR-CAT	NULL
1	NULL
£	NULL
0.2	NULL
PA62R-CATmut1	NULL
2.1	NULL
£	NULL
0.4	NULL
PA62R-CAT	NULL
mut2	NULL
1	NULL
%	NULL
0.1	NULL
PA62R-CATmut3	NULL
1.1	NULL
£	NULL
0.3	NULL
DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
R-PK	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
62-bp	NULL
promoter	NULL
fragment	NULL
from	NULL
the	NULL
R-PK	NULL
gene	NULL
is	NULL
sufficient	NULL
for	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
transient	NULL
transfection	NULL
assay	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
a	NULL
CCACC/Sp1	NULL
binding	NULL
site	NULL
around	NULL
-50	NULL
associated	NULL
to	NULL
a	NULL
GATA	NULL
binding	NULL
site	NULL
around	NULL
-20	NULL
.	NULL

Such	NULL
an	NULL
association	NULL
of	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
a	NULL
ubiquitous	NULL
protein	NULL
and	NULL
a	NULL
GATA-1	NULL
protein	NULL
is	NULL
common	NULL
to	NULL
many	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
it	NULL
has	NULL
been	NULL
described	NULL
for	NULL
promoters	NULL
of	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
(	NULL
35	NULL
,	NULL
39	NULL
,	NULL
40	NULL
)	NULL
,	NULL
murine	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
41	NULL
)	NULL
,	NULL
human	NULL
3-globin	NULL
(	NULL
42	NULL
)	NULL
,	NULL
mouse	NULL
GATA-1	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
in	NULL
locus	NULL
control	NULL
region	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
2	NULL
of	NULL
human	NULL
8	NULL
gene	NULL
cluster	NULL
(	NULL
38	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
CCACC/Sp1	NULL
binding	NULL
site	NULL
(	NULL
pA30R-CAT	NULL
)	NULL
reduced	NULL
promoter	NULL
expression	NULL
to	NULL
10	NULL
%	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
by	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
CCACC	NULL
site	NULL
of	NULL
human	NULL
PBGD	NULL
promoter	NULL
(	NULL
18	NULL
%	NULL
,	NULL
Ref	NULL
.	NULL

40	NULL
)	NULL
,	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
CCACC	NULL
site	NULL
of	NULL
mouse	NULL
GATA-1	NULL
promoter	NULL
(	NULL
22	NULL
%	NULL
,	NULL
Ref	NULL
.	NULL

43	NULL
)	NULL
,	NULL
or	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
of	NULL
the	NULL
mouse	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
16	NULL
%	NULL
,	NULL
Ref	NULL
.	NULL

41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
respective	NULL
involvement	NULL
of	NULL
CCACC	NULL
or	NULL
Sp1	NULL
proteins	NULL
is	NULL
not	NULL
completely	NULL
cleared	NULL
up	NULL
:	NULL
pA62R-CATmut1	NULL
,	NULL
which	NULL
only	NULL
allows	NULL
Sp1	NULL
binding	NULL
,	NULL
displays	NULL
a	NULL
40	NULL
%	NULL
lessening	NULL
of	NULL
promoter	NULL
expression	NULL
.	NULL

As	NULL
the	NULL
different	NULL
forms	NULL
of	NULL
CCACC	NULL
boxes	NULL
that	NULL
have	NULL
been	NULL
described	NULL
are	NULL
always	NULL
Spl	NULL
binding	NULL
sites	NULL
(	NULL
45	NULL
)	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
possible	NULL
to	NULL
design	NULL
a	NULL
mutated	NULL
site	NULL
retaining	NULL
only	NULL
the	NULL
CCACC	NULL
binding	NULL
.	NULL

So	NULL
the	NULL
respective	NULL
functions	NULL
of	NULL
Spl	NULL
and	NULL
CCACC	NULL
proteins	NULL
are	NULL
hard	NULL
to	NULL
determine	NULL
.	NULL

The	NULL
actual	NULL
role	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
vivo	NULL
should	NULL
be	NULL
in	NULL
relation	NULL
with	NULL
their	NULL
respective	NULL
affinity	NULL
for	NULL
site	NULL
B	NULL
and	NULL
their	NULL
intracellular	NULL
concentration	NULL
.	NULL

The	NULL
withdrawal	NULL
of	NULL
GATA	NULL
binding	NULL
by	NULL
point	NULL
mutations	NULL
abolished	NULL
the	NULL
expression	NULL
of	NULL
R-PK	NULL
promoter	NULL
in	NULL
the	NULL
case	NULL
of	NULL
mutant	NULL
2	NULL
,	NULL
where	NULL
the	NULL
GATA	NULL
site	NULL
was	NULL
simply	NULL
suppressed	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
case	NULL
of	NULL
mutant	NULL
3	NULL
where	NULL
the	NULL
GATA	NULL
site	NULL
was	NULL
substituted	NULL
by	NULL
a	NULL
consensus	NULL
TFIID	NULL
binding	NULL
site	NULL
.	NULL

There	NULL
have	NULL
been	NULL
some	NULL
arguments	NULL
in	NULL
favor	NULL
of	NULL
the	NULL
function	NULL
of	NULL
GATA-1	NULL
in	NULL
transcriptional	NULL
initiation	NULL
(	NULL
46	NULL
)	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
the	NULL
noncanonical	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
chicken	NULL
8-globin	NULL
gene	NULL
is	NULL
a	NULL
site	NULL
for	NULL
GATA-1	NULL
binding	NULL
(	NULL
47	NULL
)	NULL
.	NULL

On	NULL
account	NULL
of	NULL
the	NULL
similarity	NULL
of	NULL
position	NULL
and	NULL
sequence	NULL
of	NULL
site	NULL
A	NULL
with	NULL
a	NULL
TATA	NULL
box	NULL
,	NULL
we	NULL
become	NULL
interested	NULL
in	NULL
studying	NULL
the	NULL
consequences	NULL
of	NULL
the	NULL
substitution	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
by	NULL
a	NULL
TATA	NULL
box	NULL
and	NULL
the	NULL
binding	NULL
specificity	NULL
of	NULL
the	NULL
two	NULL
motifs	NULL
.	NULL

Replacing	NULL
the	NULL
GATA	NULL
site	NULL
by	NULL
a	NULL
TATA	NULL
box	NULL
reduces	NULL
the	NULL
promoter	NULL
expression	NULL
to	NULL
almost	NULL
baseline	NULL
in	NULL
erythroid	NULL
cells	NULL
and	NULL
does	NULL
not	NULL
allow	NULL
5436	NULL
expression	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
contrast	NULL
with	NULL
those	NULL
obtained	NULL
for	NULL
the	NULL
rat	NULL
platelet	NULL
factor	NULL
4	NULL
gene	NULL
promoter	NULL
for	NULL
which	NULL
substitution	NULL
of	NULL
a	NULL
GATA	NULL
site	NULL
by	NULL
a	NULL
TATA	NULL
box	NULL
allows	NULL
megakaryocytic	NULL
expression	NULL
but	NULL
entails	NULL
a	NULL
loss	NULL
of	NULL
tissue	NULL
specificity	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Possibly	NULL
,	NULL
these	NULL
different	NULL
results	NULL
are	NULL
the	NULL
consequence	NULL
of	NULL
different	NULL
functions	NULL
of	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
interesting	NULL
to	NULL
collate	NULL
our	NULL
results	NULL
with	NULL
those	NULL
obtained	NULL
in	NULL
the	NULL
study	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
chicken	NULL
B-globin	NULL
gene	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Two	NULL
GATA	NULL
sites	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
chicken	NULL
$	NULL
-globin	NULL
gene	NULL
transcription	NULL
,	NULL
one	NULL
located	NULL
at	NULL
-30	NULL
,	NULL
the	NULL
other	NULL
located	NULL
in	NULL
the	NULL
distal	NULL
3	NULL
'	NULL
enhancer	NULL
.	NULL

The	NULL
substitution	NULL
of	NULL
the	NULL
-30	NULL
GATA	NULL
site	NULL
by	NULL
a	NULL
TATA	NULL
box	NULL
reduces	NULL
by	NULL
3-fold	NULL
the	NULL
in	NULL
vivo	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
but	NULL
does	NULL
not	NULL
impair	NULL
its	NULL
in	NULL
vitro	NULL
transcription	NULL
while	NULL
a	NULL
similar	NULL
mutation	NULL
in	NULL
R-PK	NULL
promoter	NULL
nearly	NULL
abolished	NULL
erythroid	NULL
expression	NULL
.	NULL

Band	NULL
shift	NULL
experiments	NULL
demonstrate	NULL
a	NULL
strong	NULL
binding	NULL
of	NULL
cGATA-1	NULL
and	NULL
a	NULL
weak	NULL
binding	NULL
of	NULL
hTFIID	NULL
on	NULL
the	NULL
-30	NULL
chicken	NULL
B-globin	NULL
GATA	NULL
site	NULL
,	NULL
while	NULL
R-PK	NULL
site	NULL
A	NULL
binds	NULL
hGATA-1	NULL
but	NULL
does	NULL
not	NULL
bind	NULL
hT'FIID	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
chicken	NULL
B-globin	NULL
transcription	NULL
,	NULL
the	NULL
authors	NULL
propose	NULL
that	NULL
,	NULL
in	NULL
a	NULL
first	NULL
step	NULL
,	NULL
cGATA-1	NULL
binds	NULL
to	NULL
the	NULL
-30	NULL
site	NULL
and	NULL
interacts	NULL
with	NULL
cGATA-1	NULL
or	NULL
other	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
3	NULL
'	NULL
enhancer	NULL
,	NULL
allowing	NULL
the	NULL
subsequent	NULL
displacement	NULL
of	NULL
the	NULL
-30	NULL
bound	NULL
cGATA-1	NULL
by	NULL
a	NULL
TFIID-adaptor	NULL
complex	NULL
.	NULL

Such	NULL
a	NULL
model	NULL
can	NULL
not	NULL
be	NULL
applied	NULL
to	NULL
the	NULL
R-PK	NULL
promoter	NULL
which	NULL
is	NULL
efficiently	NULL
expressed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
enhancer	NULL
element	NULL
and	NULL
in	NULL
which	NULL
the	NULL
direct	NULL
binding	NULL
on	NULL
the	NULL
GATA	NULL
site	NULL
of	NULL
TFIID	NULL
alone	NULL
or	NULL
in	NULL
association	NULL
with	NULL
GATA-1	NULL
seems	NULL
unlikely	NULL
or	NULL
too	NULL
unstable	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
nuclear	NULL
components	NULL
to	NULL
be	NULL
displayed	NULL
.	NULL

Pugh	NULL
and	NULL
Tjian	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
have	NULL
implicated	NULL
TFIID	NULL
complexing	NULL
through	NULL
co-activators	NULL
and	NULL
a	NULL
tethering	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
by	NULL
Spl	NULL
of	NULL
a	NULL
TATA-less	NULL
promoter	NULL
.	NULL

Such	NULL
a	NULL
complex	NULL
could	NULL
be	NULL
speculated	NULL
in	NULL
the	NULL
transcription	NULL
activator	NULL
function	NULL
of	NULL
GATA-L	NULL
.	NULL

Throughout	NULL
this	NULL
work	NULL
,	NULL
we	NULL
have	NULL
assumed	NULL
that	NULL
the	NULL
only	NULL
GATA	NULL
protein	NULL
involved	NULL
in	NULL
R-PK	NULL
promoter	NULL
expression	NULL
was	NULL
GATA-1	NULL
.	NULL

GATA-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
whose	NULL
members	NULL
recognize	NULL
a	NULL
sequence	NULL
T/AGATAG/A	NULL
.	NULL

In	NULL
chicken	NULL
,	NULL
three	NULL
mRNAs	NULL
coding	NULL
for	NULL
GATA	NULL
proteins	NULL
have	NULL
been	NULL
described	NULL
.	NULL

GATA-1	NULL
mRNA	NULL
is	NULL
very	NULL
abundant	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
GATA-2	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
erythroid	NULL
cells	NULL
and	NULL
in	NULL
several	NULL
other	NULL
tissues	NULL
,	NULL
and	NULL
GATA-3	NULL
mRNA	NULL
is	NULL
restricted	NULL
to	NULL
developing	NULL
brain	NULL
and	NULL
T	NULL
lymphocytes	NULL
(	NULL
51	NULL
)	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
GATA-1	NULL
mRNA	NULL
has	NULL
been	NULL
assigned	NULL
to	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast	NULL
cells	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

GATA-2	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
including	NULL
HeLa	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
HEL	NULL
cells	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Among	NULL
hemato-poietic	NULL
cells	NULL
,	NULL
GATA-3	NULL
mRNA	NULL
is	NULL
restricted	NULL
to	NULL
T	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
presence	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
most	NULL
likely	NULL
that	NULL
GATA-1	NULL
is	NULL
involved	NULL
in	NULL
R-PK	NULL
promoter	NULL
expression	NULL
for	NULL
several	NULL
reasons	NULL
:	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
the	NULL
two	NULL
mRNAs	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
protection	NULL
of	NULL
site	NULL
A	NULL
to	NULL
DNase	NULL
I	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
R-PK	NULL
promoter	NULL
is	NULL
inactive	NULL
in	NULL
HeLa	NULL
cells	NULL
that	NULL
contain	NULL
GATA-2	NULL
mRNA	NULL
but	NULL
is	NULL
transactivated	NULL
by	NULL
GATA-1	NULL
in	NULL
these	NULL
same	NULL
HeLa	NULL
cells	NULL
.	NULL

Forced	NULL
expression	NULL
of	NULL
hGATA-1	NULL
in	NULL
HeLa	NULL
cells	NULL
entails	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
R-PK	NULL
promoter	NULL
constructs	NULL
when	NULL
an	NULL
intact	NULL
GATA	NULL
motif	NULL
is	NULL
present	NULL
.	NULL

The	NULL
level	NULL
of	NULL
this	NULL
transactivation	NULL
(	NULL
2-3-fold	NULL
)	NULL
was	NULL
low	NULL
compared	NULL
to	NULL
the	NULL
published	NULL
results	NULL
for	NULL
synthetic	NULL
promoter	NULL
constructs	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
or	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
no	NULL
transactivation	NULL
was	NULL
obtained	NULL
for	NULL
the	NULL
mouse	NULL
GATA-1	NULL
gene	NULL
promoter	NULL
in	NULL
NIH-3T3	NULL
(	NULL
43	NULL
)	NULL
or	NULL
the	NULL
entire	NULL
human	NULL
-globin	NULL
gene	NULL
or	NULL
the	NULL
y-globin	NULL
promoter	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
authors	NULL
invoke	NULL
the	NULL
requirement	NULL
for	NULL
additional	NULL
tissue-restricted	NULL
factors	NULL
(	NULL
57	NULL
)	NULL
which	NULL
also	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
R-PK	NULL
promoter	NULL
function	NULL
,	NULL
although	NULL
less	NULL
drastically	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
CCACC/Sp1	NULL
binding	NULL
site	NULL
does	NULL
not	NULL
influence	NULL
the	NULL
level	NULL
of	NULL
the	NULL
hGATA-1	NULL
transactivation	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
is	NULL
essential	NULL
in	NULL
erythroid-specific	NULL
promoter	NULL
activity	NULL
,	NULL
also	NULL
argues	NULL
in	NULL
favor	NULL
of	NULL
the	NULL
need	NULL
of	NULL
additional	NULL
factors	NULL
as	NULL
the	NULL
occurrence	NULL
of	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
R-PK	NULL
promoter	NULL
constructs	NULL
(	NULL
1-3-fold	NULL
the	NULL
basal	NULL
level	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
in	NULL
the	NULL
megakaryocytic	NULL
cell	NULL
line	NULL
MEG-O1	NULL
,	NULL
which	NULL
expresses	NULL
the	NULL
GATA-1	NULL
protein	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
inhibiting	NULL
effect	NULL
of	NULL
TPA	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
R-PK	NULL
promoter	NULL
is	NULL
maintained	NULL
in	NULL
pA62R-CAT	NULL
.	NULL

Owing	NULL
to	NULL
the	NULL
structure	NULL
of	NULL
this	NULL
core	NULL
promoter	NULL
,	NULL
GATA-1	NULL
could	NULL
be	NULL
an	NULL
intermediate	NULL
of	NULL
this	NULL
effect	NULL
as	NULL
TPA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down-regulate	NULL
this	NULL
factor	NULL
(	NULL
37	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
demonstrated	NULL
that	NULL
TPA	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
megakaryocytic	NULL
markers	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
59	NULL
)	NULL
.	NULL

So	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
a	NULL
common	NULL
factor	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
repression	NULL
of	NULL
R-PK	NULL
promoter	NULL
in	NULL
MEG-O1	NULL
cells	NULL
and	NULL
TPA-treated	NULL
K562	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
TPA	NULL
is	NULL
mediated	NULL
by	NULL
several	NULL
events	NULL
,	NULL
including	NULL
down-regulation	NULL
of	NULL
GATA-1	NULL
and	NULL
effects	NULL
on	NULL
factors	NULL
which	NULL
do	NULL
not	NULL
bind	NULL
the	NULL
DNA	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
present	NULL
study	NULL
demonstrated	NULL
that	NULL
a	NULL
short	NULL
promoter	NULL
fragment	NULL
(	NULL
62	NULL
bp	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
mediate	NULL
an	NULL
erythroid	NULL
tissue	NULL
specificity	NULL
and	NULL
a	NULL
substantial	NULL
level	NULL
of	NULL
expression	NULL
.	NULL

This	NULL
very	NULL
simple	NULL
promoter	NULL
could	NULL
be	NULL
a	NULL
useful	NULL
tool	NULL
in	NULL
a	NULL
more	NULL
acute	NULL
study	NULL
of	NULL
initiation	NULL
of	NULL
transcription	NULL
,	NULL
including	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
the	NULL
search	NULL
for	NULL
interaction	NULL
between	NULL
tissue-specific	NULL
and	NULL
general	NULL
transcription	NULL
factors	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Professor	NULL
J.	NULL
Rosa	NULL
for	NULL
encouragement	NULL
and	NULL
all	NULL
members	NULL
of	NULL
the	NULL
laboratory	NULL
for	NULL
constant	NULL
support	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
J.	NULL
Ham	NULL
for	NULL
providing	NULL
the	NULL
pKB104	NULL
plasmid	NULL
,	NULL
to	NULL
V.	NULL
Mignotte	NULL
for	NULL
providing	NULL
the	NULL
pGAA	NULL
construct	NULL
,	NULL
and	NULL
to	NULL
C.	NULL
Rahuel	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
the	NULL
GpB	NULL
oligonucleotides	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
J.	NULL
Gillespie	NULL
for	NULL
his	NULL
careful	NULL
revision	NULL
of	NULL
the	NULL
text	NULL
,	NULL
R.	NULL
Quintel	NULL
,	NULL
C.	NULL
Beauchaints	NULL
,	NULL
and	NULL
M.	NULL
Segear	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
R.	NULL
Chalumeau	NULL
and	NULL
A.-M.	NULL
Dulac	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
figures	NULL
,	NULL
and	NULL
J.-M.	NULL
Massé	NULL
for	NULL
photographic	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
.	NULL

Minakami	NULL
,	NULL
S.	NULL
&	NULL
Yoshikawa	NULL
,	NULL
H.	NULL
(	NULL
1966	NULL
)	NULL
J.	NULL
Biochem	NULL
.	NULL

(	NULL
Tokyo	NULL
)	NULL
59	NULL
,	NULL
139-144	NULL
.	NULL

Imamura	NULL
,	NULL
K.	NULL
&	NULL
Tanaka	NULL
,	NULL
T.	NULL
(	NULL
1972	NULL
)	NULL
J.	NULL
Biochem	NULL
.	NULL

(	NULL
Tokyo	NULL
)	NULL
71	NULL
,	NULL
1048-1051	NULL
.	NULL

Nogéuschi	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
&	NULL
Tanaka	NULL
,	NULL
T.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261	NULL
,	NULL
13807-13812	NULL
.	NULL

Noguchi	NULL
,	NULL
T.	NULL
,	NULL
Yamada	NULL
,	NULL
K.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
&	NULL
Tanaka	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
14366-14371	NULL
.	NULL

Osterman	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Fritz	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Biochemistry	NULL
13	NULL
,	NULL
1731-1736	NULL
.	NULL

Max-Audit	NULL
,	NULL
I.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Kechemir	NULL
,	NULL
D.	NULL
,	NULL
Titeux	NULL
,	NULL
M.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
&	NULL
Rosa	NULL
,	NULL
R.	NULL
(	NULL
1984	NULL
)	NULL
Blood	NULL
64	NULL
,	NULL
930-936	NULL
.	NULL

Takegawa	NULL
S.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
&	NULL
M1wa	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

54	NULL
,	NULL
467-474	NULL
.	NULL

Nijhof	NULL
,	NULL
W.	NULL
Wlerenga	NULL
P.	NULL
K.	NULL
,	NULL
Staal	NULL
G.	NULL
E.	NULL
L.	NULL
&	NULL
Jansen	NULL
,	NULL
G.	NULL
(	NULL
1984	NULL
)	NULL
Blood	NULL
64	NULL
,	NULL
607-613	NULL
.	NULL

Max-Audit	NULL
,	NULL
I.	NULL
,	NULL
Kechemir	NULL
,	NULL
D.	NULL
,	NULL
Mitjavila	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Rotten	NULL
,	NULL
D.	NULL
&	NULL
Rosa	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
72	NULL
,	NULL
1039-1044	NULL
.	NULL

Cognet	NULL
,	NULL
M.	NULL
,	NULL
Lone	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
Vaulont	NULL
,	NULL
S.	NULL
,	NULL
Kahn	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Marie	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

196	NULL
,	NULL
11-25	NULL
.	NULL

Noguchi	NULL
,	NULL
T.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Matsubara	NULL
,	NULL
K.	NULL
&	NULL
Tanaka	NULL
,	NULL
T.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

258	NULL
,	NULL
15220-15223	NULL
.	NULL

Decaux	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Antoine	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Kahn	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
11584-11590	NULL
©	NULL
pa	NULL
su	NULL
eo	NULL
sme	NULL
Ho	NULL
el	NULL
-o	NULL
w	NULL
nm	NULL
9	NULL
o	NULL
.	NULL

Vaulont	NULL
,	NULL
S.	NULL
,	NULL
Puzenat	NULL
,	NULL
N.	NULL
,	NULL
Levrat	NULL
,	NULL
F.	NULL
,	NULL
Cognet	NULL
M.	NULL
,	NULL
Kahn	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Raymondjean	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

209	NULL
,	NULL
205-21	NULL
.	NULL

Vaulont	NULL
,	NULL
S.	NULL
,	NULL
Puzenat	NULL
,	NULL
N.	NULL
,	NULL
Kahn	NULL
A	NULL
.	NULL

&	NULL
Raymondjean	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
4409—4415	NULL
.	NULL

Yamada	NULL
,	NULL
K.	NULL
,	NULL
Noguchi	NULL
,	NULL
T.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Takenaka	NULL
,	NULL
M.	NULL
,	NULL
Monaci	NULL
,	NULL
P.	NULL
,	NULL
Nicosia	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Tanaka	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
19885-19891	NULL
-	NULL
Cognet	NULL
M.	NULL
,	NULL
Bergot	NULL
,	NULL
M.	NULL
O	NULL
.	NULL

&	NULL
Kahn	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
7368-	NULL
.	NULL

Thompson	NULL
,	NULL
K.	NULL
S.	NULL
&	NULL
Towle	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8679-8682	NULL
.	NULL

Bergot	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Diaz-	NULL
Guerra	NULL
M.	NULL
J.	NULL
M.	NULL
,	NULL
Puzenat	NULL
,	NULL
N.	NULL
,	NULL
Raymondjean	NULL
,	NULL
M.	NULL
&	NULL
Kahn	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
1871-1878	NULL
.	NULL

Tremp	NULL
,	NULL
G	NULL
L.	NULL
,	NULL
Bogquet	NULL
,	NULL
D.	NULL
,	NULL
Ripoche	NULL
,	NULL
M.	NULL
A	NULL
Cognet	NULL
,	NULL
M.	NULL
,	NULL
Lone	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
Jami	NULL
,	NULL
J.	NULL
,	NULL
Kahn	NULL
,	NULL
A	NULL
&	NULL
Daegelen	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Bwl	NULL
hem	NULL
.	NULL

264	NULL
19904	NULL
19910	NULL
.	NULL

Yamada	NULL
K.	NULL
,	NULL
Noguchi	NULL
,	NULL
T.	NULL
,	NULL
Miyazaki	NULL
,	NULL
J.	NULL
,	NULL
Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Takenaka	NULL
,	NULL
N.	NULL
,	NULL
Ya-mamura	NULL
,	NULL
K	NULL
&	NULL
Tanaka	NULL
,	NULL
T	NULL
(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

'Res	NULL
.	NULL

Commun	NULL
.	NULL

171	NULL
Hoot	NULL
et	NULL
&	NULL
of	NULL
A	NULL
edad	NULL
go	NULL
1	NULL
oo	NULL
0	NULL
w	NULL
243-249	NULL
21	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
Blom	NULL
van	NULL
Assendelft	NULL
,	NULL
G.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
&	NULL
Kollias	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
975-985	NULL
22	NULL
.	NULL

Chao	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Mellon	NULL
,	NULL
P.	NULL
,	NULL
Charnay	NULL
,	NULL
P.	NULL
,	NULL
Maniatis	NULL
,	NULL
T.	NULL
&	NULL
Axel	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
32	NULL
,	NULL
483-493	NULL
23	NULL
.	NULL

Lozzio	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

&	NULL
Lozzio	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1975	NULL
)	NULL
Blood	NULL
45	NULL
,	NULL
321-334	NULL
24	NULL
.	NULL

Martin	NULL
,	NULL
P.	NULL
&	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
216	NULL
,	NULL
1233-1235	NULL
25	NULL
.	NULL

Rutherford	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Clegg	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Weatherall	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Nature	NULL
280	NULL
,	NULL
164-165	NULL
26	NULL
.	NULL

Fukuda	NULL
,	NULL
M	NULL
(	NULL
1981	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

41	NULL
,	NULL
4621-4628	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

R-PK	NULL
Promoter	NULL
Regulatory	NULL
Elements	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Yokochi	NULL
,	NULL
T.	NULL
,	NULL
Chait	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Kannagi	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Blood	NULL
62	NULL
,	NULL
832-845	NULL
Luckow	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Schiitz	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
5490	NULL
Ellis	NULL
,	NULL
L.	NULL
,	NULL
Clauser	NULL
,	NULL
E.	NULL
,	NULL
Morgan	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
Edery	NULL
,	NULL
R.	NULL
,	NULL
Roth	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
721-732	NULL
Kao	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
Schmidt	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Zhou	NULL
,	NULL
Q.	NULL
,	NULL
Pei	NULL
,	NULL
R.	NULL
&	NULL
Berk	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
1646-1650	NULL
De	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
De	NULL
Luca	NULL
,	NULL
M.	NULL
,	NULL
Helinski	NULL
,	NULL
D.	NULL
&	NULL
Subramani	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
725-737	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
C.	NULL
F.	NULL
&	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Nguyen	NULL
,	NULL
V.	NULL
T.	NULL
,	NULL
Morange	NULL
,	NULL
M.	NULL
&	NULL
Bensaude	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

171	NULL
,	NULL
404-408	NULL
Dignam	NULL
,	NULL
S.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Wall	NULL
,	NULL
L.	NULL
,	NULL
De	NULL
Boer	NULL
,	NULL
E.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
&	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
37-54	NULL
De	NULL
Boer	NULL
,	NULL
E.	NULL
,	NULL
Antoniou	NULL
,	NULL
M	NULL
Mignotte	NULL
,	NULL
W.	NULL
,	NULL
Wall	NULL
,	NULL
L.	NULL
&	NULL
Grosveld	NULL
,	NULL
F.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
EMBOJ	NULL
7	NULL
,	NULL
4203-	NULL
421	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Navarro	NULL
S.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I	NULL
.	NULL

&	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
22090-22092	NULL
Philipsen	NULL
,	NULL
S.	NULL
,	NULL
Talbot	NULL
,	NULL
D.	NULL
,	NULL
Fraser	NULL
,	NULL
P.	NULL
&	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2159-2167	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Raich	NULL
,	NULL
N.	NULL
&	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
6548-6552	NULL
Frampton	NULL
,	NULL
S.	NULL
,	NULL
Walker	NULL
,	NULL
M.	NULL
,	NULL
Plumb	NULL
,	NULL
M.	NULL
&	NULL
Harrison	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3838-3842	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
10638-10641	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54.	NULL
.	NULL

Dorfman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
5437	NULL
De	NULL
Boer	NULL
,	NULL
E.	NULL
,	NULL
Antoniou	NULL
,	NULL
M	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Wall	NULL
,	NULL
L.	NULL
&	NULL
Grosveld	NULL
,	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
4203-421	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Strauss	NULL
E.	NULL
&	NULL
Orkm	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
919-931	NULL
Reddy	NULL
,	NULL
P	NULL
M.	NULL
S.	NULL
&	NULL
Shen	NULL
,	NULL
C	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8676-B680	NULL
Yu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Motamed	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Bailey	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Shen	NULL
,	NULL
C.-K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8907-8915	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
665—672	NULL
Fong	NULL
,	NULL
T.	NULL
C.	NULL
&	NULL
Emerson	NULL
,	NULL
B.	NULL
M	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
521-532	NULL
Ravid	NULL
,	NULL
K.	NULL
,	NULL
Doi	NULL
,	NULL
T.	NULL
,	NULL
Beeler	NULL
D.	NULL
L.	NULL
,	NULL
Kuter	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

&	NULL
Rosenberg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
6116-6127	NULL
Pugh	NULL
,	NULL
B.	NULL
F.	NULL
&	NULL
Tjian	NULL
,	NULL
'	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
1187-1197	NULL
Pugh	NULL
,	NULL
B.	NULL
F.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1985-1945	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Engel	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1650-1662	NULL
Miiun	NULL
D7	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I	NULL
Mutter	NULL
,	NULL
G.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
844	NULL
,	NULL
4-44	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Prandini	NULL
,	NULL
H	NULL
,	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Vain-chenker	NULL
W	NULL
Marguerle	NULL
.	NULL

&	NULL
Uzan	NULL
,	NULL
a	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
447	NULL
449	NULL
Lee	NULL
,	NULL
M.	NULL
E	NULL
Temlzer	NULL
D.	NULL
H.	NULL
,	NULL
Clifford	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Quertermous	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
266	NULL
,	NULL
16188	NULL
16192	NULL
Wilson	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Bruns	NULL
,	NULL
G.	NULL
A.	NULL
P.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
1279-1285	NULL
.	NULL

JouMlin	NULL
,	NULL
V.	NULL
,	NULL
Bories	NULL
,	NULL
D.	NULL
,	NULL
Eleouet	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Labastie	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Chretien	NULL
,	NULL
S.	NULL
,	NULL
Mattei	NULL
,	NULL
&	NULL
Roméo	NULL
,	NULL
P.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1809-1816	NULL
.	NULL

Mariin	NULL
,	NULL
lD	NULL
.	NULL

I.	NULL
K.	NULL
&	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1886-1898	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
&	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
843-853	NULL
.	NULL

Tabilio	NULL
,	NULL
A.	NULL
,	NULL
Pelicci	NULL
,	NULL
P.	NULL
G	NULL
Vinci	NULL
,	NULL
G.	NULL
,	NULL
Mannoni	NULL
,	NULL
P.	NULL
,	NULL
Clvm	NULL
C.L	NULL
,	NULL
Vamchenker	NULL
Tesa	NULL
U.	NULL
,	NULL
L1pmsk1	NULL
M.	NULL
,	NULL
Rochant	NULL
M.	NULL
&	NULL
Breton-	NULL
Gonus	NULL
(	NULL
1983	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

43	NULL
4569-4574	NULL

